Boris Nikolic

Biography

Boris Nikolic has served as a member of the Editas board of directors since August 2015. Dr. Nikolic has served as Managing Director of investment fund bng0, LLC since February 2015 and as Managing Partner of investment fund Biomatics Capital since April 2014. From April 2009 to April 2014, he served as Chief Advisor for Science and Technology to Bill Gates at bgC3. From 2002 to 2010, Dr. Nikolic was an assistant professor at Harvard Medical School. He currently serves on the board of directors of BlueTalon, Inc. and Digisight Technologies, Inc., both private software companies, and Omniome, Inc., a private biotechnology company. He previously served on the board of directors of Schrödinger, LLC, a private chemical simulation software company. His academic research at Harvard Medical School focused on the field of immunogenetics and translational immunology. Dr. Nikolic has received numerous national and international awards and managed international teams of scientists. He has been selected as a field expert scientist for peer review committees, study sections, and professional associations. Dr. Nikolic is the author of more than 70 articles, patents, and patent applications, and he is co-founder of three biotechnology companies. Dr. Nikolic earned his M.D. from the Zagreb Medical School in Zagreb, Croatia and completed his postdoctoral fellowship in transplantation immunology at Harvard Medical School.

Research Interest

transplantation immunology, immunogenetics and translational immunology